5,923 reports of this reaction
2.2% of all CORTISONE ACETATE reports
#5 most reported adverse reaction
ALOPECIA is the #5 most commonly reported adverse reaction for CORTISONE ACETATE, manufactured by Boiron. There are 5,923 FDA adverse event reports linking CORTISONE ACETATE to ALOPECIA. This represents approximately 2.2% of all 272,029 adverse event reports for this drug.
Patients taking CORTISONE ACETATE who experience alopecia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ALOPECIA is a less commonly reported adverse event for CORTISONE ACETATE, but still significant enough to appear in the safety profile.
In addition to alopecia, the following adverse reactions have been reported for CORTISONE ACETATE:
The following drugs have also been linked to alopecia in FDA adverse event reports:
ALOPECIA has been reported as an adverse event in 5,923 FDA reports for CORTISONE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ALOPECIA accounts for approximately 2.2% of all adverse event reports for CORTISONE ACETATE, making it a notable side effect.
If you experience alopecia while taking CORTISONE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.